Janssen's COVID-19 Vaccine Distribution Initiated

As a centralized distribution partner for the U.S. government’s COVID vaccine distribution effort, Irving-based McKesson announced today it began distributing the Janssen COVID-19 vaccine received from Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

The Janssen COVID-19 vaccine received Emergency Use Authorization from the U.S. FDA on February 27, 2021, and is the first one-shot COVID-19 vaccine to be authorized for use in the United States.

The U.S. government selected McKesson in August 2020 to operate as the centralized distributor for frozen and refrigerated COVID-19 vaccines and ancillary supply kits needed to administer them.

In December 2020, McKesson began distributing the ancillary supply kits for Pfizer BioNTech’s COVID-19 vaccine. Later that month, the company began distributing Moderna’s COVID-19 vaccine and ancillary supply kits.

McKesson is a global leader in healthcare and supply chain management, is managing different aspects of the distribution efforts in coordination with the U.S. government.